Form 4: Arbutus Biopharma CFO Reports Stock Transaction
Insider Transaction (Form 4)
Tuan Nguyen, Chief Financial Officer of Arbutus Biopharma Corp, reported multiple transactions in common stock on September 18, 2026.
Summary
- Option exercise/conversion: acquired 265,625 Common Shares at $3.49 ($927,031) on September 18, 2026; holds 339,125 after (Direct).
- Option exercise/conversion: acquired 27,475 Common Shares at $4.39 ($120,615) on September 18, 2026; holds 366,600 after (Direct).
- Tax/exercise-price withholding: disposed of 206,637 Common Shares at $5.07 ($1,047,650) on September 18, 2026; holds 159,963 after (Direct).
- Option exercise/conversion: disposed of 265,625 Stock Option (Right to Buy) on September 18, 2026; holds 484,375 after (Direct).
- Option exercise/conversion: disposed of 27,475 Stock Option (Right to Buy) on September 18, 2026; holds 160,925 after (Direct).
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.
Insider Transactions
Tuan Nguyen — Officer (Chief Financial Officer)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-09-18 | Option exercise/conversion | Common Shares | 265,625 | $3 | $927.0K | 339,125 |
| 2026-09-18 | Option exercise/conversion | Common Shares | 27,475 | $4 | $120.6K | 366,600 |
| 2026-09-18 | Tax/exercise-price withholding | Common Shares | 206,637 | $5 | $1.0M | 159,963 |
| 2026-09-18 | Option exercise/conversion | Stock Option (Right to Buy) | 265,625 | — | — | 484,375 |
| 2026-09-18 | Option exercise/conversion | Stock Option (Right to Buy) | 27,475 | — | — | 160,925 |
Key Dates
| Date | Description |
|---|---|
| 2026-09-18 | Option exercise/conversion (265,625 shares) |
| 2026-09-18 | Option exercise/conversion (27,475 shares) |
| 2026-09-18 | Tax/exercise-price withholding (206,637 shares) |
| 2026-09-18 | Option exercise/conversion (265,625 shares) |
| 2026-09-18 | Option exercise/conversion (27,475 shares) |
Keywords
insider transaction, Form 4, ABUS, Arbutus Biopharma Corp, neutral, Tuan Nguyen
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.